{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:46:23Z","timestamp":1761126383626},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,8,15]],"date-time":"2002-08-15T00:00:00Z","timestamp":1029369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> In this national study, we have evaluated a new intensive chemotherapy protocol for adult patients with untreated acute lymphoblastic leukaemia (ALL). One hundred and fifty\u2010three patients with median age 42\u2003years received induction therapy with high\u2010dose cytarabine (Ara\u2010C), cyclophosphamide, daunorubicin, vincristine and betamethasone. A high complete remission (CR) rate (90%) was achieved in patients &lt;\u200a60\u2003years compared with 70% in patients &gt;\u200a60\u2003years (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7004). The estimated 3\u2003year overall survival for all patients was 29% (CI\u200321\u201336%) and the estimated continuous complete remission (CCR) at 3\u2003years for the patients achieving CR according to the protocol was 36% (CI\u200327\u201345%). A favourable pretreatment characteristic was pre\u2010B phenotype, especially for patients &lt;\u200a40\u2003years without any high\u2010risk factor, with an estimated CCR at 3\u2003years of 62% (CI\u200341\u201382%). Stem cell transplantation (SCT) as post\u2010remission therapy, mainly for high\u2010risk patients, gave an estimated 3\u2003year disease free survival (DFS) after SCT of 39% (CI\u200324\u201354%). No significant differences in DFS could be found between autologous, related or unrelated donor transplantation. We conclude that this intensive protocol resulted in a high CR rate combined with acceptable side\u2010effects and a favourable CCR for patients with pre\u2010B ALL.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03685.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:47:01Z","timestamp":1047365221000},"page":"748-754","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["High\u2010dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"118","author":[{"given":"Helene","family":"Hallb\u00f6\u00f6k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Carneskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Grimfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kimby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Linderholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"L\u00f6fvenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Malm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per\u2010Gunnar","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Stenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Stockelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Tidefelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann\u2010Marie","family":"Uden\u2010Blome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Vilen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingemar","family":"Winquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Smedmyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,8,15]]},"reference":[{"key":"e_1_2_24_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900301)65:5<1079::AID-CNCR2820650506>3.0.CO;2-K"},{"key":"e_1_2_24_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1572"},{"key":"e_1_2_24_4_1","first-page":"3931","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364","volume":"93","author":"Czuczman M.S.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_24_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700964"},{"key":"e_1_2_24_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01698484"},{"key":"e_1_2_24_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.10.1990"},{"key":"e_1_2_24_8_1","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique","volume":"87","author":"Group Francais de Cytogenetique Hematologique","year":"1996","journal-title":"Blood"},{"key":"e_1_2_24_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/080352598750031149"},{"key":"e_1_2_24_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401970"},{"key":"e_1_2_24_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.6.927"},{"key":"e_1_2_24_12_1","first-page":"1","article-title":"Treatment of acute lymphoblastic leukemia","volume":"31","author":"Hoelzer D.","year":"1994","journal-title":"Seminars in Hematology"},{"key":"e_1_2_24_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.123.123"},{"key":"e_1_2_24_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495"},{"key":"e_1_2_24_15_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.V73.1.57.57","article-title":"Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy","volume":"73","author":"Hussein K.K.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_24_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04982.x"},{"key":"e_1_2_24_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.547"},{"key":"e_1_2_24_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701498"},{"key":"e_1_2_24_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025"},{"key":"e_1_2_24_20_1","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V78.11.2814.2814","article-title":"Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow\u2010up report","volume":"78","author":"Linker C.A.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_24_21_1","first-page":"182","article-title":"GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results","volume":"6","author":"Mandelli F.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_24_22_1","first-page":"3294","article-title":"Improved treatment results in childhood B\u2010cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2010Frankfurt\u2010Munster Group Trial NHL\u2010BFM 90","volume":"94","author":"Reiter A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_24_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.6.948"},{"key":"e_1_2_24_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.4.1410"},{"key":"e_1_2_24_25_1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood.V80.7.1813.1813","article-title":"Acute lymphoblastic leukemia in patients aged 60 years and over: a population\u2010based study of incidence and outcome","volume":"80","author":"Taylor P.R.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_24_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.1083"},{"key":"e_1_2_24_27_1","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey N.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_24_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057986"},{"key":"e_1_2_24_29_1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","article-title":"Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia","volume":"90","author":"Weisdorf D.J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_24_30_1","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience","volume":"93","author":"Wetzler M.","year":"1999","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03685.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03685.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03685.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:48:52Z","timestamp":1697442532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03685.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,15]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03685.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03685.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,15]]},"assertion":[{"value":"2002-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}